Wednesday, March 20, 2019 11:32:36 AM
ACRX $3.475 Presenting in about 3+ hrs. There will be a small window for listeners to buy stock after presentation or early tomorrow. Hopefully positive response from knowledgeable attendees.
Oppenheimer 29th Annual Healthcare Conference
Date: Wednesday, March 20, 2019
Location: Westin Grand Central, New York, NY
Presentation Time: 2:45 pm ET (11:45 a.m. PT)
The conference presentation will be webcast live and can be accessed through the Investors page at www.acelrx.com. For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.acelrx.com.
Oppenheimer 29th Annual Healthcare Conference
Date: Wednesday, March 20, 2019
Location: Westin Grand Central, New York, NY
Presentation Time: 2:45 pm ET (11:45 a.m. PT)
The conference presentation will be webcast live and can be accessed through the Investors page at www.acelrx.com. For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.acelrx.com.
Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.
If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE
Recent TLPH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 09:01:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:31:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:10:24 PM
- Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/13/2026 08:05:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/12/2026 05:22:56 PM
- Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026 • PR Newswire (US) • 05/07/2026 08:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2026 08:34:28 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2026 08:31:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 10:10:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 10:09:19 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/02/2026 04:15:30 AM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 04/01/2026 08:37:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 11:57:56 PM
- Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 • PR Newswire (US) • 03/25/2026 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 08:05:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 12:35:09 PM
- Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • PR Newswire (US) • 03/23/2026 12:30:00 PM
- Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 • PR Newswire (US) • 03/18/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:30:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 12:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:05:21 PM
- Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial • PR Newswire (US) • 03/02/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2026 01:28:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2026 01:27:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2026 01:23:20 AM
